ELICIO THERAPEUTICS INC. - COMMON STOCK

8.2700

10-July-25 13:45:00

15 minutes delayed

Stocks

-0.0200

-0.24%

Today's range

8.1400 - 8.4000

ISIN

N/A

Source

NASDAQ

Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting

03 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer

02 Jun 2023 13:30:00 By Nasdaq GlobeNewswire
Elicio Therapeutics Announces Completion of Merger with Angion Biomedica

01 Jun 2023 13:04:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.